10-K: SCWorx Corp. Reports Annual Results for 2023, Faces Going Concern Uncertainty

SCWorx Corp.'s annual report reveals a net loss of $3.98 million for 2023 and raises substantial doubt about the company's ability to continue as a going concern.

Summary

• SCWorx Corp. reported a net loss of $3.98 million for the year ended December 31, 2023, compared to a net loss of $1.85 million in 2022.
• The company's revenue decreased by 5.7% to $3.80 million in 2023 from $4.04 million in 2022.
• Operating losses were $1.45 million in 2023 and $2.13 million in 2022.
• The company's accumulated deficit reached $29.84 million by the end of 2023.
• Auditors have expressed substantial doubt about SCWorx's ability to continue as a going concern due to limited cash, a working capital deficit of $1.9 million, and ongoing losses.
• The company used $806,164 of cash in operations during 2023.
• SCWorx implemented a 1-for-15 reverse stock split on October 11, 2023.
• The company is actively seeking additional capital through equity and debt financing.
• SCWorx's software solutions are delivered to clients within a fixed term period, typically a three-to-five-year contracted term, using a SaaS delivery method.

Sentiment

Score: 2

Explanation: The document paints a very negative picture due to significant losses, declining revenue, a going concern warning, and internal control issues. The company's financial health is precarious, and its future is uncertain.

Positives

• General and administrative expenses decreased by $817,337 in 2023, primarily due to decreases in non-cash stock compensation expense, legal and professional fees, and inventory write-downs.
• The company continues to provide data-driven solutions to healthcare providers.
• SCWorx has a data warehouse exceeding 12 million items, which is a key strength.

Negatives

• The company has a history of losses and may continue to incur losses in the future.
• SCWorx's revenue declined by approximately $233,000 in 2023.
• The company has a working capital deficit of $1,898,625.
• The company has limited cash on hand.
• The company is experiencing negative cash flows from operations.
• The company's customer base is highly concentrated, with a few customers representing a substantial portion of revenue.
• The company's internal control over financial reporting has not been effective due to a lack of segregation of duties.

Risks

• The COVID-19 pandemic has disrupted the company's business and the business of its hospital customers.
• There is substantial doubt about the company's ability to continue as a going concern.
• The company has an immediate need for additional capital.
• The company's contracts may require extra work, leading to disputes and delays.
• The loss of a significant customer could adversely affect the company's business.
• The company's failure to expand its direct sales force will impede growth.
• The company's dependence on subcontractors and suppliers could increase costs and impair its ability to complete contracts.
• The company's industry is highly competitive, with larger companies having greater resources.
• Economic downturns could cause capital expenditures in the industries the company serves to decrease.
• The company's operating results may fluctuate due to factors that are difficult to forecast.
• The company's common stock price has fluctuated substantially and is likely to continue to be volatile.
• The company may be unable to establish, protect, or enforce its intellectual property rights adequately.
• Disruptions in the company's information technology systems or security breaches could have an adverse impact on operations.

Future Outlook

The company expects to continue to incur operating losses and will need to generate significant increases in product revenues to achieve profitability. The company is actively seeking additional capital to fund its operations and implement its business plan. If the company is able to secure sufficient funding in the first half of 2024, it expects that its operations could begin to generate positive cash flows by the end of 2024.

Management Comments

• Management believes that the conditions raise substantial doubt about the company's ability to continue as a going concern.
• Management is actively seeking to raise additional funds through the sale of equity and debt securities.
• Management has concluded that the consolidated financial statements present fairly, in all material respects, the company's financial position, results of operations and cash flows for the periods presented.

Industry Context

The healthcare industry is subject to rapid changes in technology and governmental regulation, which may reduce demand for the company's services. The industry has also been characterized by a high level of consolidation that may result in the loss of customers. The company faces competition from a variety of vendors and smaller companies which provide solutions in the specific markets it addresses.

Comparison to Industry Standards

• The company's financial performance is significantly below industry standards for profitability and cash flow.
• Many competitors have greater financial and technical resources.
• The company's reliance on a few key customers is a significant risk compared to more diversified competitors.
• The company's internal control weaknesses are a concern compared to industry best practices.
• The company's need for additional capital is a significant challenge compared to more established competitors.

Legal Proceedings

• The company is involved in several legal proceedings, including an arbitration case with Core IR, a lawsuit with Hadrian Equities Partners, and a complaint from Carole R. Bernstein, Esq.
• The company has entered into settlement agreements for the Core IR and Hadrian Equities Partners cases.
• The company is obligated to indemnify its officers and directors for costs incurred in defending against these claims and investigations.

Related Party Transactions

• The company had amounts due to officers of $149,838 and $153,838 as of December 31, 2023 and 2022, respectively.
• The company had a shareholder advance of $67,622 and $100,000 as of December 31, 2023 and 2022, respectively.
• The company's CFO advanced an aggregate $193,558 in cash to the company for short term capital requirements, which was repaid by the end of 2023.

Stakeholder Impact

• Shareholders face significant risk of losing their investment due to the company's financial instability.
• Employees may be affected by potential cost-cutting measures or layoffs.
• Customers may be concerned about the company's ability to continue providing services.
• Creditors face increased risk of non-payment due to the company's financial difficulties.

Next Steps

• The company will need to secure additional financing to continue operations.
• The company will need to improve its internal controls over financial reporting.
• The company will need to focus on increasing revenue and reducing operating expenses.
• The company will need to address the issues raised by its auditors regarding its ability to continue as a going concern.

Key Dates

Keywords

healthcare, data normalization, interoperability, SaaS, supply chain, big data analytics, item master file, revenue cycle management, financial reporting, going concern